J7Z Analyst Ratings
Strong Buy
18 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
J7Z Stock 12 Month Forecast
Average Price Target
―| Highest Price TargetCHF281.87 | Average Price TargetCHF249.06 | Lowest Price TargetCHF191.54 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Citi
CHF271.83
Buy
―
Initiated
10/01/26
Piper Sandler
CHF259.29
Buy
―
Reiterated
09/28/26
Bernstein
CHF191.54
Hold
―
Reiterated
09/25/26
Goldman Sachs
CHF281.87
Buy
―
Initiated
09/24/26
UBS
CHF263.47→CHF281.87
Buy
―
Assigned
09/14/26
Barclays
CHF225.83→CHF226.67
Buy
―
Reiterated
09/10/26
Truist Financial
―
Buy
―
Reiterated
09/01/26
Needham
CHF259.29
Buy
―
Reiterated
08/31/26
TD Cowen
CHF250.92
Buy
―
Reiterated
08/31/26
Canaccord Genuity
CHF250.92
Buy
―
Reiterated
08/31/26
RBC Capital
CHF231.69→CHF250.09
Buy
―
Reiterated
08/28/26
Morgan Stanley
CHF236.7→CHF269.32
Buy
―
Assigned
08/26/26
Deutsche Bank
CHF240.05→CHF250.92
Buy
―
Reiterated
08/26/26
Bank of America Securities
CHF256.78
Buy
―
Reiterated
08/25/26
Wells Fargo
CHF250.92
Buy
―
Reiterated
08/10/26
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Citi
CHF271.83
Buy
―
Initiated
10/01/26
Piper Sandler
CHF259.29
Buy
―
Reiterated
09/28/26
Bernstein
CHF191.54
Hold
―
Reiterated
09/25/26
Goldman Sachs
CHF281.87
Buy
―
Initiated
09/24/26
UBS
CHF263.47→CHF281.87
Buy
―
Assigned
09/14/26
Barclays
CHF225.83→CHF226.67
Buy
―
Reiterated
09/10/26
Truist Financial
―
Buy
―
Reiterated
09/01/26
Needham
CHF259.29
Buy
―
Reiterated
08/31/26
TD Cowen
CHF250.92
Buy
―
Reiterated
08/31/26
Canaccord Genuity
CHF250.92
Buy
―
Reiterated
08/31/26
RBC Capital
CHF231.69→CHF250.09
Buy
―
Reiterated
08/28/26
Morgan Stanley
CHF236.7→CHF269.32
Buy
―
Assigned
08/26/26
Deutsche Bank
CHF240.05→CHF250.92
Buy
―
Reiterated
08/26/26
Bank of America Securities
CHF256.78
Buy
―
Reiterated
08/25/26
Wells Fargo
CHF250.92
Buy
―
Reiterated
08/10/26
Best Analysts Covering Jazz Pharmaceuticals
3 Months
Success Rate
13/21 ratings generated profit
Average Return
+6.68%
Copying Joseph Thome's trades and holding each position for 3 Months would result in 61.90% of your transactions generating a profit, with an average return of +6.68% per trade.
1 Year
Success Rate
19/21 ratings generated profit
Average Return
+37.86%
Copying Joseph Thome's trades and holding each position for 1 Year would result in 90.48% of your transactions generating a profit, with an average return of +37.86% per trade.
2 Years
Success Rate
20/21 ratings generated profit
Average Return
+65.13%
Copying Joseph Thome's trades and holding each position for 2 Years would result in 95.24% of your transactions generating a profit, with an average return of +65.13% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
J7Z Analyst Recommendation Trends
Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
0
0
0
0
0
Buy
31
35
54
50
41
Hold
4
4
2
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
35
39
56
51
42
Each month's total comprises the sum of three months' worth of ratings.
J7Z Financial Forecast
J7Z Stock Forecast FAQ
What is CH:J7Z’s average 12-month price target, according to analysts?
Based on analyst ratings, Jazz Pharmaceuticals’s 12-month average price target is 249.06.
What is CH:J7Z’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for CH:J7Z, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Jazz Pharmaceuticals a Buy, Sell or Hold?
Jazz Pharmaceuticals has a consensus rating of Strong Buy, which is based on 18 buy ratings, 1 hold ratings and 0 sell ratings.
What is Jazz Pharmaceuticals’s share price target?
The average share price target for Jazz Pharmaceuticals is 249.06. This is based on 19 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is CHF281.87 ,and the lowest forecast is CHF191.54. The average share price target represents N/A Increase from the current price of N/A.
The highest analyst share price target is CHF281.87 ,and the lowest forecast is CHF191.54. The average share price target represents N/A Increase from the current price of N/A.
What do analysts say about Jazz Pharmaceuticals?
Jazz Pharmaceuticals’s analyst rating consensus is a Strong Buy. This is based on the ratings of 19 Wall Streets Analysts.
How can I buy shares of Jazz Pharmaceuticals?
To buy shares of CH:J7Z, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.